Diagnosis

Improving HCV Treatment Access for People Who Inject Drugs: Co-located and Telemedicine Solutions

Sharing injection drug use equipment remains the most common mode of hepatitis C virus (HCV) transmission in the United States, but people who inject drugs…

Jennifer Geremia,

MSPAS, PA-C
Physician Associate, Brigham and Women's Hospital & Teaching Hospital of Harvard Medical School

Patient Management Guidelines

Articles

Overcoming Barriers to HCV Elimination: The Need for Point-of-Care RNA Testing

Hepatitis C virus (HCV) elimination faces barriers, including underutilization of curative treatments and gaps in testing. In the United States,...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Challenges in Eliminating Hepatitis C: Access, Awareness, and the Path to Global Eradication by 2030

Hepatitis C virus (HCV) is a major cause of chronic liver disease and a key factor in the development of...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

WHO Prequalifies First HCV Self-Test to Expand Global Access and Elimination Efforts

The World Health Organization (WHO) has prequalified the first hepatitis C virus (HCV) self-test, OraQuick HCV self-test, manufactured by OraSure...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

APOE4’s Paradoxical Role: Increased COVID-19 Severity but Protection in HCV Liver Disease

Hepatitis C virus (HCV) and COVID-19 both affect the liver and cardiovascular systems, with the APOE4 allele playing a complex...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Global HCV in Dialysis: 24.3% Prevalence Demands Urgent Action

A systematic review and meta-analysis involving 634 studies across 392,160 patients revealed a global hepatitis C virus (HCV) prevalence of...

CURATED BY:
Gabriella McCarty,
MSN, NP-C

HCV-Related CLD Deaths Surpass HBV: Global Efforts Needed to Curb Rising Mortality by 2030

An analysis of data from the Global Burden of Diseases Study (2019) revealed that hepatitis C virus (HCV)-related chronic liver...

CURATED BY:
Geraldine Joseph,
MPH, RPA-C, AAHIVM

Company
Contact

Partner with Us
Ambassador Program

Diagnosis

Improving HCV Treatment Access for People Who Inject Drugs: Co-located and Telemedicine Solutions

Jennifer Geremia,

Patient Management Guidelines

Articles

Overcoming Barriers to HCV Elimination: The Need for Point-of-Care RNA Testing

Challenges in Eliminating Hepatitis C: Access, Awareness, and the Path to Global Eradication by 2030

WHO Prequalifies First HCV Self-Test to Expand Global Access and Elimination Efforts

APOE4’s Paradoxical Role: Increased COVID-19 Severity but Protection in HCV Liver Disease

Global HCV in Dialysis: 24.3% Prevalence Demands Urgent Action

HCV-Related CLD Deaths Surpass HBV: Global Efforts Needed to Curb Rising Mortality by 2030

© 2025 Point of Care Network, LLC. All Rights Reserved.

© 2025 Point of Care Network, LLC. All Rights Reserved.

Share